Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-002139-33Phase 4Completed
Phase 4, open-label, single-arm trial of salmeterol, sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Urine concentration of salmeterol. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-002139-33.